View in EDS HTML Full Text PDF Full Text

TNFR2 antagonist and agonist: a potential therapeutics in cancer immunotherapy.

Saved in:
Bibliographic Details
Title: TNFR2 antagonist and agonist: a potential therapeutics in cancer immunotherapy.
Authors: Quazi S; GenLab Biosolutions Private Limited, Bangalore, 560043, Karnataka, India. Colonel.quazi@gmail.com.; Department of Biomedical Sciences, School of Life Sciences, Anglia Ruskin University, Cambridge, UK. Colonel.quazi@gmail.com.; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. Colonel.quazi@gmail.com.
Source: Medical oncology (Northwood, London, England) [Med Oncol] 2022 Sep 29; Vol. 39 (12), pp. 215. Date of Electronic Publication: 2022 Sep 29.
Publication Type: Journal Article; Review; Retracted Publication
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36175687
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: TNFR2 antagonist and agonist: a potential therapeutics in cancer immunotherapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Quazi+S%22">Quazi S</searchLink>; GenLab Biosolutions Private Limited, Bangalore, 560043, Karnataka, India. Colonel.quazi@gmail.com.; Department of Biomedical Sciences, School of Life Sciences, Anglia Ruskin University, Cambridge, UK. Colonel.quazi@gmail.com.; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. Colonel.quazi@gmail.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229435512%22">Medical oncology (Northwood, London, England)</searchLink> [Med Oncol] 2022 Sep 29; Vol. 39 (12), pp. 215. <i>Date of Electronic Publication: </i>2022 Sep 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Retracted Publication
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9435512 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1559-131X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213570560%22">13570560 </searchLink><i>NLM ISO Abbreviation: </i>Med Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36175687
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12032-022-01772-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 215
    Titles:
      – TitleFull: TNFR2 antagonist and agonist: a potential therapeutics in cancer immunotherapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Quazi S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 09
              Text: 2022 Sep 29
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1559-131X
          Numbering:
            – Type: volume
              Value: 39
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Medical oncology (Northwood, London, England)
              Type: main
ResultId 1